Short answer
Sanara MedTech Inc. (SMTI) filed an 8-K current report with the SEC on October 1, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events). Merger with MiMedx approved, clearing the key shareholder vote for Sanara to become MiMedx’s wholly owned subsidiary.
Sanara MedTech Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Merger with MiMedx approved, clearing the key shareholder vote for Sanara to become MiMedx’s wholly owned subsidiary
- Proposal No. 1 passed overwhelmingly: 6,372,989 for, 1,944 against, and 36,494 abstentions
- Meeting quorum reached with 6,411,427 shares, representing 69.78% of 9,188,035 outstanding shares
- Merger-related executive compensation approved on an advisory basis: 5,841,470 for, 75,247 against, and 494,710 abstentions
- Adjournment proposal not submitted because sufficient votes supported the merger proposal
Item 8.01 · Other Events
- MiMedx refiled its HSR notification September 15, restarting regulatory review of the proposed merger
- HSR waiting period scheduled to expire October 15, 2026, unless extended or terminated earlier
- Voluntary withdrawal and refiling indicate additional FTC review time, increasing deal-timing uncertainty
- Merger remains subject to other conditions under the merger agreement
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sanara MedTech Inc. 8-K filings
Get the next SMTI 8-K as it lands
Follow SMTI for push alerts, or ask the research agent what this filing means.